跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 180 条关于
“Christina Coughlin”
全部
180
临床试验
57
药物
6
机构
36
资讯
81
去年
Avacta Completes Transition to Pure-Play Therapeutics with £2.2M Coris Sale
去年
Avacta Therapeutics Raises £3.25 Million and Secures Bond Amendment to Advance FAP-Dox Cancer Therapy
11个月前
Avacta Develops First Dual-Payload Peptide Drug Conjugate Platform for Cancer Combination Therapy
9个月前
Avacta's Faridoxorubicin Shows Promising Tumor Shrinkage in Salivary Gland Cancer Phase 1b Trial
2年前
Avacta's AVA6000 Shows Durable Responses in FAP-Positive Solid Tumors with Reduced Toxicity
7个月前
Avacta Therapeutics Promotes Francis Wilson to Chief Scientific Officer to Lead pre|CISION Platform Development
去年
Avacta's AVA6000 Shows Promise in Salivary Gland Cancer Trial
去年
Avacta Strengthens Leadership Team with Appointment of Chief Medical Officer and Business Development Advisor
去年
Avacta Therapeutics Sells Launch Diagnostics for £12.9M to Focus on Cancer Drug Development
3个月前
Vir Biotechnology Appoints Timothy Coughlin to Board of Directors Amid Pipeline Advancement
第 1 页,共 9 页
上一页
下一页